Insiders · Profile

Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER at Travere Therapeutics. Filing since 2 Oct 2020. CIK 0001789617

Company

Date

Role

Action

Shares

Amount

Of holding

TVTX Travere Therapeutics, Inc.

17 Sep 2026

EVP, CHIEF COMMERCIAL OFFICER

Sold on a plan

8,282

$538.92K

6.6%

TVTX Travere Therapeutics, Inc.

16 Sep 2026

EVP, CHIEF COMMERCIAL OFFICER

Sold on a plan

172,717

$10.96M

59.6%

TVTX Travere Therapeutics, Inc.

15 Sep 2026

EVP, CHIEF COMMERCIAL OFFICER

Sold on a plan

102,190

$6.36M

46.6%

TVTX Travere Therapeutics, Inc.

5 May 2026

CHIEF COMMERCIAL OFFICER

Sold at will

2,174

$101.42K

1.5%

TVTX Travere Therapeutics, Inc.

14 Apr 2026

CHIEF COMMERCIAL OFFICER

Sold at will

7,215

$302.52K

4.9%

TVTX Travere Therapeutics, Inc.

3 Feb 2026

CHIEF COMMERCIAL OFFICER

Sold at will

7,310

$234.80K

5.3%

TVTX Travere Therapeutics, Inc.

24 Dec 2025

CHIEF COMMERCIAL OFFICER

Sold on a plan

4,980

$199.20K

4.2%

TVTX Travere Therapeutics, Inc.

31 Oct 2025

CHIEF COMMERCIAL OFFICER

Sold on a plan

5,591

$195.69K

4.5%

TVTX Travere Therapeutics, Inc.

28 Oct 2025

CHIEF COMMERCIAL OFFICER

Sold on a plan

2,662

$79.86K

2.1%

TVTX Travere Therapeutics, Inc.

5 May 2025

CHIEF COMMERCIAL OFFICER

Sold at will

1,771

$37.28K

1.4%

TVTX Travere Therapeutics, Inc.

12 Feb 2025

CHIEF COMMERCIAL OFFICER

Sold on a plan

2,568

$60.43K

2.0%

TVTX Travere Therapeutics, Inc.

11 Feb 2025

CHIEF COMMERCIAL OFFICER

Sold on a plan

3,074

$76.85K

2.4%

TVTX Travere Therapeutics, Inc.

3 Feb 2025

CHIEF COMMERCIAL OFFICER

Sold at will

5,166

$103.94K

4.0%

TVTX Travere Therapeutics, Inc.

22 Jan 2025

CHIEF COMMERCIAL OFFICER

Sold at will

1,584

$30.00K

1.5%

TVTX Travere Therapeutics, Inc.

9 Sep 2024

CHIEF COMMERCIAL OFFICER

Sold at will

2,191

$25.24K

2.0%

TVTX Travere Therapeutics, Inc.

1 Feb 2024

CHIEF COMMERCIAL OFFICER

Sold at will

4,195

$35.79K

4.0%

TVTX Travere Therapeutics, Inc.

23 Jan 2024

CHIEF COMMERCIAL OFFICER

Sold at will

1,559

$14.14K

1.9%

TVTX Travere Therapeutics, Inc.

3 Oct 2023

Chief Commercial Officer

Sold at will

3,091

$25.50K

3.7%

TVTX Travere Therapeutics, Inc.

1 Feb 2023

Chief Commercial Officer

Sold, plan not stated

1,779

$38.70K

2.1%

TVTX Travere Therapeutics, Inc.

24 Jan 2023

Chief Commercial Officer

Sold, plan not stated

1,550

$33.95K

2.4%

TVTX Travere Therapeutics, Inc.

4 Oct 2022

Chief Commercial Officer

Sold, plan not stated

3,042

$78.12K

4.5%

TVTX Travere Therapeutics, Inc.

31 Jan 2022

Chief Commercial Officer

Sold, plan not stated

1,125

$30.83K

1.6%

TVTX Travere Therapeutics, Inc.

24 Jan 2022

Chief Commercial Officer

Sold, plan not stated

1,875

$46.84K

3.1%

TVTX Travere Therapeutics, Inc.

4 Oct 2021

Chief Commercial Officer

Sold, plan not stated

3,058

$75.75K

4.8%

TVTX Travere Therapeutics, Inc.

17 Aug 2021

Chief Commercial Officer

Sold, plan not stated

1,407

$24.09K

2.2%

TVTX Travere Therapeutics, Inc.

8 Feb 2021

Chief Commercial Officer

Sold, plan not stated

1,125

$35.53K

1.9%

TVTX Travere Therapeutics, Inc.

5 Feb 2021

Chief Commercial Officer

Sold, plan not stated

1,125

$35.34K

1.8%

TVTX Travere Therapeutics, Inc.

3 Feb 2021

Chief Commercial Officer

Sold, plan not stated

563

$16.28K

1.0%

TVTX Travere Therapeutics, Inc.

2 Feb 2021

Chief Commercial Officer

Sold, plan not stated

563

$17.31K

1.0%

TVTX Travere Therapeutics, Inc.

5 Oct 2020

Chief Commercial Officer

Sold, plan not stated

2,188

$42.34K

4.9%

TVTX Travere Therapeutics, Inc.

2 Oct 2020

Chief Commercial Officer

Sold, plan not stated

2,188

$41.35K

4.7%

31 decisions on file.